Toggle navigation
Home
Search
Services
Blog
Contact
About
Sponge Microcarriers for Continuous Cell Culture
Phillips, Philip G.
Verax Corporation, Lebanon, NH, United States
Search 24 grants from Philip Phillips
Search grants from Verax Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Building Community Capacity for Disability Prevention for Minority Elders
Mechanisms of Adipocyte Death
Wound Healing, S Aureus Peptidoglycan and Subunits
Computer Aided Ultrasonic Diagnosis: Imaging, Prostate, Cancer, 3D, Skin, Breast
Molecular Studies of Collagen in the Skeletal Dysplasias
Recently added grants:
The Role of Lung Resident Mesenchymal Stem Cells in Post-Chemotherapy Lung Metastases of Breast Cancer
Dissecting EGFR Inhibitor Resistance in Glioblastoma through genome-wide CRISPR screening
Understanding how metabolic heterogeneity in cancer affects the tumor microenvironment and anti-tumor immunity
Ex vivo analysis of human brain tumor cells in a microvascular niche model
Long-term Effects of IDU, HIV, HCV and the Impact of HCV Cure on Immune Activation and Liver Fibrosis in Aging Women
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
9R44GM035657-02
Application #
3507809
Study Section
(SSS)
Project Start
1985-04-01
Project End
1987-03-31
Budget Start
1985-04-01
Budget End
1986-03-31
Support Year
2
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Verax Corporation
Department
Type
DUNS #
City
Lebanon
State
NH
Country
United States
Zip Code
Related projects
NIH 1986
R44 GM
Sponge Microcarriers for Continuous Cell Culture
Hayman, Edward G. / Verax Corporation
NIH 1985
R44 GM
Sponge Microcarriers for Continuous Cell Culture
Phillips, Philip G. / Verax Corporation
Comments
Be the first to comment on Philip Phillips's grant